Chronic Kidney Disease: A Global Health Crisis
The number of adults living with chronic kidney disease (CKD) has more than doubled since 1990, reaching nearly 800 million worldwide, according to a recent study published in The Lancet. This alarming statistic highlights a growing global health crisis that demands urgent attention. The study, led by researchers at the Institute for Health Metrics and Evaluation (IHME) and other prestigious institutions, provides a comprehensive assessment of the fatal and non-fatal burden of CKD worldwide.
CKD is a leading cause of death and disability, with nearly 1.5 million lives claimed and 12th-leading cause of disability in 2023. What sets CKD apart is its increasing global age-standardized mortality rate, rising from 24.9 per 100,000 in 1990 to 26.5 per 100,000 in 2023. This trend is particularly concerning, as it diverges from the decline in mortality rates seen in most other leading causes of death.
China and India bear the brunt of this crisis, with 152 million and 138 million people affected, respectively. However, CKD is a global issue, with the United States, Indonesia, Japan, Brazil, Russia, Mexico, Nigeria, Pakistan, Bangladesh, Iran, the Philippines, Vietnam, Thailand, and Turkey each reporting more than 10 million adults living with the disease. These numbers underscore the widespread nature of CKD and its impact on diverse populations.
The study also reveals CKD's significant contribution to cardiovascular disease, accounting for almost 12% of global cardiovascular deaths in 2023. Diabetes and high blood pressure are identified as the primary risk factors, contributing to a loss of healthy years of life. Obesity, dietary factors like low fruit and vegetable intake, and high sodium consumption also play a role in the development of CKD.
The burden of CKD is not evenly distributed globally, with the highest prevalence found in North Africa and the Middle East (18.0%), South Asia (15.8%), sub-Saharan Africa (15.6%), and Latin America and the Caribbean (15.4%). Countries like Iran, Haiti, Panama, Nigeria, Mauritius, Seychelles, Grenada, Mexico, Libya, and Costa Rica have some of the highest rates of CKD. This disparity highlights the need for targeted interventions in regions facing the greatest health inequities.
The study emphasizes the importance of early detection and risk-reducing strategies. Most people with CKD are in the early stages (stages 1-3), which means that screening programs and accessible treatments to control blood sugar and blood pressure can significantly reduce cardiovascular mortality and delay the need for costly kidney replacement therapies. However, access to these therapies remains limited and uneven worldwide, underscoring the need for greater emphasis on disease prevention and equitable care.
In conclusion, the rising prevalence of CKD is a global health crisis that requires urgent action. By addressing key risk factors, expanding access to diagnosis and affordable care, and investing in disease prevention strategies, we can work towards reducing the growing toll of CKD on patients, families, and health systems worldwide.
